Turn Therapeutics (TTRX) Change in Accured Expenses (2024 - 2026)

Turn Therapeutics' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at -$613464.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 2853.75% year-over-year to -$613464.0; the TTM figure through Mar 2026 stood at $80654.0 (changed N/A YoY), while the FY2025 annual figure was $2.3 million, up 1015.95% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$613464.0, down from $664303.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $664303.0 in Q4 2025, with the low at -$613464.0 in Q1 2026.
• The 3-year median for Change in Accured Expenses is $14907.5 (2024), against an average of $20163.5.
• The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses jumped 1213.27% in 2025, then slumped 2853.75% in 2026.
• Turn Therapeutics' Change in Accured Expenses stood at $50584.0 in 2024, then surged by 1213.27% to $664303.0 in 2025, then slumped by 192.35% to -$613464.0 in 2026.
• Business Quant data shows TTRX's Change in Accured Expenses at -$613464.0 in Q1 2026, $664303.0 in Q4 2025, and -$20769.0 in Q1 2025.